← FDA Drug Approvals (Drugs@FDA)

HYPAQUE-M,90%

NDA · New Drug Application · Sponsor: GE HEALTHCARE · Approved 1955-11-09

Drug application

FDA Application #

NDA010220

Application type

New Drug Application

Brand name

HYPAQUE-M,90%

Generic name

Diatrizoate Meglumine

Active ingredients

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

GE HEALTHCARE

First approval

1955-11-09

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown